Angiogenesis Inhibitors: all 4,430 studies that test it
Page 39 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.
- PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced MalignanciesCompletedNCT00611793Phase 1
- Ph I SU011248 + Irinotecan in Treatment of Pts w MGCompletedNCT00611728Phase 1
- Bevacizumab and Temsirolimus in Patients With Advanced MalignancyCompletedNCT00610493Phase 1
- Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL AmyloidosisCompletedNCT00607581Phase 2
- Neoadjuvant Endostatin and Chemotherapy for Breast CancerCompletedNCT00604435Phase 2
- Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250CompletedNCT00602862Not applicable
- Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic CancerCompletedNCT00602602Phase 2
- Thalidomide Versus Bortezomib in Melphalan Refractory MyelomaCompletedNCT00602511Phase 3
- MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal CancerTerminatedNCT00602329Phase 2
- A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid LeukemiaWithdrawnNCT00601991Phase 2
- Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control StudyWithdrawnNCT00600301Phase 3
- Intravitreal Bevacizumab for Diabetic RetinopathyTerminatedNCT00600262Phase 2/3
- Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix CancerWithdrawnNCT00600210Phase 2
- Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid StreaksTerminatedNCT00599820Phase 3
- Preoperative Bevacizumab for Vitreous HemorrhageCompletedNCT00596297Phase 1/2
- Lucentis for Age-related Macular Degeneration Pigment Epithelial DetachmentsCompletedNCT00590694Phase 2/3
- BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)CompletedNCT00586443Phase 1
- A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid TumorsCompletedNCT00586092Phase 1
- Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal AdenocarcinomaCompletedNCT00583674Phase 2
- Interaction Study of Rapamycin and Sunitinib in Patients With Advanced CancersCompletedNCT00583063Early Phase 1
- Erlotinib and Sunitinib in NSCLCCompletedNCT00581789Phase 1
- A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With MyelodysplasiaCompletedNCT00580242Phase 1
- SU011248 for Platinum-Refractory Urothelial Cancer Evaluation TrialCompletedNCT00578526Phase 2
- Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung CancerCompletedNCT00578149Phase 2
- A Pilot Study of the Combination of Melphalan, Bortezomib, Thalidomide and Dexamethasone (MEL-VTD)WithdrawnNCT00577668Phase 2
- Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung CancerStatus unknownNCT00576914Phase 3
- Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate CancerCompletedNCT00574769Phase 1/2
- Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMDCompletedNCT00574093Phase 2
- UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total TherapyActive, not recruitingNCT00572169Phase 3
- Treatment of Failing Blebs With RanibizumabCompletedNCT00570726Phase 1
- Photodynamic and Pharmacologic Treatment of CNVCompletedNCT00570193Phase 1/2
- Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569790Phase 2
- Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)CompletedNCT00569699Phase 2
- Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569335Phase 2
- Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00568048Phase 2
- A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVOCompletedNCT00567697Phase 3
- POSTERIOR SUB-TENON'S AvastinWithdrawnNCT00567372Phase 4
- Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVOTerminatedNCT00566761Phase 4
- A Trial of Bevacizumab in Myelodysplastic Syndromes (Int-1, Int-2 and High Risk According to International Prognostic Scoring System (IPSS)) With Excess of Marrow BlastsTerminatedNCT00565656Phase 2
- Intravitreal Avastin in Proliferative RetinopathiesCompletedNCT00564148Phase 2
- Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)CompletedNCT00562406Not applicable
- Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerWithdrawnNCT00560495Phase 1
- Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and RanibizumabStatus unknownNCT00559715Phase 3
- XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal AdenocarcinomaStatus unknownNCT00557713Phase 2
- Intraocular Bevacizumab (Avastin) for Rubeosis IridisCompletedNCT00557232Phase 4
- Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular DegenerationCompletedNCT00556348Phase 4
- Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell CarcinomaWithdrawnNCT00556205Phase 2
- LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid TumorsCompletedNCT00556088Phase 1
- Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal NeovascularizationCompletedNCT00555594Phase 2/3
- A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00555256Phase 1
- Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple MyelomaCompletedNCT00555100Phase 1
- Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma PatientsCompletedNCT00551928Phase 3
- Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic CancerCompletedNCT00550927Phase 1
- Sutent Maintenance After Response to TaxotereStatus unknownNCT00550810Phase 2
- Ranibizumab Versus PDT for Presumed Ocular HistoplasmosisStatus unknownNCT00546936Phase 2
- Bevacizumab Versus Ranibizumab for Diabetic RetinopathyCompletedNCT00545870Phase 3
- A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer PatientsCompletedNCT00545246Phase 1
- Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal CancerTerminatedNCT00544700Phase 3
- Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00544011Phase 2
- Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal CancerCompletedNCT00543842Phase 1
- Bevacizumab in Multiple Phase I CombinationsCompletedNCT00543504Phase 1
- Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLLTerminatedNCT00543114Phase 1
- Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase InhibitorCompletedNCT00543049Phase 2
- G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal CancerCompletedNCT00541125Phase 2
- Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell CancerCompletedNCT00541008Phase 2
- Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque RadiotherapyStatus unknownNCT00540930Phase 4
- Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant MelanomaStatus unknownNCT00538005Phase 1/2
- First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International StudyCompletedNCT00537901Not applicable
- SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma MultiformeStatus unknownNCT00535379Phase 2
- BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00533585Phase 1
- Evaluation of Dosing Interval of Higher Doses of RanibizumabCompletedNCT00533520Phase 4
- Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal CancerCompletedNCT00532909Phase 1
- Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma.CompletedNCT00532675Phase 1
- A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248CompletedNCT00531544Not applicable
- MAAM Study: Avastin and Macugen Versus Avastin Versus MacugenCompletedNCT00531336Phase 2
- Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung CancerTerminatedNCT00531076Phase 1
- Systemic Avastin Therapy in Age-Related Macular DegenerationCompletedNCT00531024Phase 2/3
- Valproic Acid and Bevacizumab in Patients With Advanced CancerCompletedNCT00530907Phase 1
- A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid TumorsCompletedNCT00528619Phase 1
- Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy AdultsCompletedNCT00528489Phase 1
- Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma PatientsCompletedNCT00527657Phase 1
- Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple MyelomaCompletedNCT00525447Phase 1
- Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic PatientsStatus unknownNCT00524875Not applicable
- Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By SurgeryWithdrawnNCT00524069Not applicable
- Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCCTerminatedNCT00522249Phase 1/2
- Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent GlioblastomaStatus unknownNCT00521482Phase 2
- Sunitinib Malate in Treating East African Patients With Kaposi SarcomaWithdrawnNCT00521092Phase 2
- UFUR Plus Thalidomide for Advanced Hepatocellular CarcinomaCompletedNCT00519688Phase 2
- A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal CancerTerminatedNCT00516841Phase 2
- Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring VitrectomyStatus unknownNCT00516464Phase 3
- Corneal Thinning During Topical Bevacizumab TherapyWithdrawnNCT00515684Not applicable
- Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00514228Phase 2
- Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryStatus unknownNCT00513266Phase 2
- Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid TumorsCompletedNCT00511849Phase 1
- Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer PatientsCompletedNCT00511459Phase 2
- Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)CompletedNCT00510965Phase 2
- Thyroid Cancer and SunitinibCompletedNCT00510640Phase 2
- A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- BevacizumabCompletedNCT00508625Phase 2
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and AvastinCompletedNCT00507585Phase 1
- Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular DegenerationCompletedNCT00504959Phase 4